Northpond Ventures
Venture Capital
Active
Bethesda, United States
114
41M
68
19.00
26
0.40
3
- Stages of investment
- Areas of investment
Summary
In 2018 was created Northpond Ventures, which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Bethesda.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Northpond Ventures, startups are often financed by ARCH Venture Partners, Sands Capital Ventures, Connecticut Innovations. The meaningful sponsors for the fund in investment in the same round are Sands Capital Ventures, Think.Health, Spring Mountain Capital. In the next rounds fund is usually obtained by National Cancer Institute SBIR Development Center, Think.Health, Spring Mountain Capital.
The real fund results show that this VC is 64 percentage points more often commits exit comparing to other companies. The fund is generally included in 13-24 deals every year. The top activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The current fund was established by Michael Rubin, Sharon Kedar. Besides them, we counted 3 critical employees of this fund in our database.
Among the various public portfolio startups of the fund, we may underline Ultivue, 908 Devices, Candel Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical, Software. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investor highlights
- Industry focus
- Stage focus
- Check size
- Up to 10M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 114
- Lead investments
- 26
- Exits
- 3
- Rounds per year
- 19.00
- Follow on index
- 0.40
- Investments by industry
- Biotechnology (84)
- Health Care (52)
- Medical (30)
- Health Diagnostics (29)
- Life Science (26) Show 39 more
- Investments by region
-
- United States (104)
- United Kingdom (4)
- Switzerland (1)
- Australia (3)
- Germany (2)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 6M
- Group Appearance index
- 0.84
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Elephas Biosciences | 30 Nov 2023 | Health Care, Medical Device, Medical | Late Stage Venture | 55M | United States, Wisconsin, Madison |
EnPlusOne Biosciences | 30 Sep 2022 | Biotechnology, Therapeutics | Seed | 12M | United States, Massachusetts, Watertown |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.